How Predictive AI Is Rewriting the Contract Between Insurers and the Insured in India
- Dr. Kavindra Kumar Singh, Chief Technology Officer, SMC Insurance Brokers Pvt Ltd
- 6 hours ago
- 7 min read
There is a quiet but profound shift happening in Indian health insurance, one that does not announce itself with flashy product launches or regulatory press releases, but one that will, over the next decade, fundamentally alter what it means to be an insurer. The shift is this: the industry is slowly, imperfectly, but unmistakably moving from a model built around paying for illness to one that is beginning to invest in preventing it.
For most of the industry's history in India, health insurance worked as a financial instrument, not a health one. A policyholder paid a premium; the insurer paid a claim. The insurer's job was to price risk accurately, process claims efficiently and manage fraud. The policyholder's health journey (whether they smoked, walked 10,000 steps a day, managed their stress, or skipped their annual check-up) was largely invisible to the insurer until it showed up as a hospitalisation bill.
Artificial intelligence and specifically predictive modelling built on health data, is changing this. It is not changing it overnight and it is not changing it without ethical complexity. But the direction of travel is clear: insurers that learn to act on signals before they become claims will operate fundamentally differently (and far more sustainably) than those that do not.
The industry is moving from a model built around paying for illness to one that invests in preventing it.
The Problem With Waiting
To understand why pre-loss intervention matters so much, it helps to understand just how expensive the current model is. India's health insurance claims ratio has been under sustained pressure.
Non-life insurance incurred claims ratio reached 82.88% in FY2024-25, indicating high payouts relative to premiums.
Healthcare costs in India are projected to rise around 13% annually, higher than the global average.
Rising hospitalisation costs, an ageing insured base, the rapid growth of non-communicable diseases and the lingering burden of post-pandemic health deterioration have all converged to make reactive claims payment an increasingly costly proposition.
Why India's Health Insurance Model Is Under Pressure
The deeper problem is that by the time a claim arrives, the most expensive damage has often already been done. A patient hospitalized for a cardiac event did not become a cardiac risk overnight. The trajectory was there in their metabolic indicators, in their lifestyle patterns, in their family history, in the creeping escalation of their blood pressure readings over three annual check-ups. The insurer saw none of it, because it was not their job to look.
Predictive AI makes it their job to look. The ethical lines here matter enormously, but systematically. The data already exists in many cases. Medical records, pharmacy claims, diagnostic lab reports, wearable device outputs, employer wellness programme data. What has been missing is the analytical infrastructure to connect these signals, score them and translate them into a meaningful intervention before hospitalisation becomes inevitable.
What Predictive Health AI Actually Does?
It is worth being precise here. Predictive health AI, as it applies to pre-loss intervention, is specifically about risk stratification and early action. In practical terms, this means building models that can ingest structured and unstructured health data. It includes diagnostic codes, prescription patterns, lab values, self-reported wellness data, etc. It outputs a probability score that a specific individual is on a trajectory toward a costly health event within a defined future window. Twelve months, Twenty-four months. The model does not need to be perfect. It needs to be better than random, better than intuition and better than the current default, which is to act on nothing until a claim arrives.
Once a high-risk individual is identified, the intervention layer kicks in. This is where the distribution and engagement side of the ecosystem becomes critical. An insurer that identifies a diabetic patient with deteriorating HbA1c trends can proactively reach out through their distribution partners to offer a structured disease management programme. A health coach. A teleconsultation with a specialist. An incentive to complete a retinal screening. A nudge, at the right moment, to the right person, through a channel they trust.
That last piece: the trusted channel. This is where technology-forward insurance intermediaries play a role that is often underestimated. In a country as large and as diverse as India, insurers cannot build last-mile engagement at scale on their own. The companies that are already embedded in the policyholder's financial life are often better positioned to deliver that nudge than the insurer's own customer service team. When that intermediary is also digitally enabled, with access to the customer's profile and policy data, the intervention becomes far more personalised and far more likely to land.
Remember: The most expensive damage has often already been done by the time a claim arrives. Predictive AI changes when the insurer enters the story.
The Indian Context
Deploying predictive health AI in India comes with challenges that are specific to the Indian market and should not be glossed over in any serious discussion of the topic.
Data Fragmentation:
Unlike some Western markets where electronic health records are relatively consolidated, India's health data is scattered. Lab reports live on WhatsApp as PDFs. Prescription histories are rarely digitised. ABHA (Ayushman Bharat Health Account) is a promising step toward longitudinal health records, but adoption is uneven and the ecosystem is still maturing. Until health data flows more freely and more consistently, predictive models will be working with partial pictures. That does not make them useless as partial pictures are still better than no picture. But it does mean that model outputs need to be interpreted with appropriate humility.
Diversity of the Risk Pool:
India's insured population spans urban professionals with access to premium diagnostics and rural policyholders for whom the nearest hospital is two hours away. A predictive model trained predominantly on urban, English-speaking, smartphone-enabled data will not generalise cleanly to the rest of the market. Building models that are genuinely inclusive (that work for the PMJAY beneficiary and the corporate group health member) requires deliberate investment in representative training data and culturally sensitive engagement design.
Trust:
Indian policyholders are, understandably, cautious about sharing health data with financial institutions. The spectre of premium hikes and coverage exclusions based on health data is a real concern that any insurer or intermediary working in this space must address head-on. The value exchange must be explicit: if you share your health data, here is what you get in return - a discount, personalized wellness programme, or even earlier access to care. The terms must be clear, the consent must be genuine and the benefit must be real. Anything less will erode the trust that the model depends on.
The Ethical Architecture of Pre-Loss Intervention
This brings us to the ethical dimension, which cannot be treated as an afterthought. The same AI that can identify a high-risk individual and connect them with care can also be used, if poorly governed, to exclude that individual from affordable coverage. This is the central ethical tension in predictive health insurance: the same model that enables intervention also enables discrimination.
The industry needs to be clear, both with regulators and with customers, that predictive models used in wellness and pre-loss intervention contexts are distinct from underwriting models. The data gathered for intervention should not automatically feed back into pricing and exclusion decisions without explicit consent frameworks and regulatory oversight. This is not just an ethical position; it is a practical one. If policyholders believe that sharing their health data will result in higher premiums or coverage denial, they will not share it and the entire value proposition of predictive health AI collapses.
The same model that enables intervention also enables discrimination. The ethical architecture must be built before the product is launched, not after.
What the Shift Looks Like in Practice
For a product or technology leader in the insurance space, the questions are practical: what does building toward pre-loss intervention actually require and where do you start?
Data Infrastructure:
Before any predictive model can run, there needs to be a clean, structured, consented dataset to run it on. For most insurers and intermediaries, this means investing in better data capture at the point of policy issuance and renewal — not just the standard demographic fields, but meaningful health proxy data. It means building integrations with diagnostic labs, with pharmacy networks, with wearable device platforms where customers are willing to connect them. It means treating every customer interaction as an opportunity to enrich the health profile, always with consent, always with a clear value exchange.
Genuine Wellness Engagement Layer:
Predictive models are only as useful as the interventions they trigger. If the model identifies a high-risk individual and the only response is a generic email from the insurer's call centre, the value is minimal. The intervention needs to be personalised, timely, delivered through a channel the customer trusts and connected to a real service — a doctor, a health coach, a diagnostic package, a disease management programme. Building this layer requires partnerships: with healthcare providers, with wellness platforms, with digital health companies. No single player can own the entire stack.
Feedback Loop:
Predictive health AI is not a one-time deployment. Models need to be retrained as new data comes in, as interventions succeed or fail, as the health landscape shifts. The companies that will lead in this space will be those that treat their predictive infrastructure as a living system rather than a deployed product. It involves continuously learning, continuously improving and continuously being honest about where their models are wrong.
Where This Is Headed?
The long-term trajectory of predictive health AI in Indian insurance is not difficult to sketch, even if the timeline is uncertain. Within the next five years, we will see the first cohort of Indian insurers who can demonstrate, with actuarial rigour, that their pre-loss intervention programmes have materially reduced hospitalisation rates among identified high-risk cohorts. When that evidence exists, the business case for predictive AI moves from interesting to undeniable.
At that point, the competitive dynamic in health insurance changes. The insurers who have built the data infrastructure, the engagement layers and the analytical capabilities will have a structural advantage that is very difficult to replicate quickly. They will know their customers better. They will price risk more accurately. They will retain customers longer, because a customer who has received genuine value like a timely intervention, a health outcome they would not otherwise have had, is a customer who renews. For the intermediary ecosystem as well, the shift is equally significant.
Some intermediaries, including long-standing advisory platforms such as SMC Insurance, are also beginning to experiment with how digital data layers can support more proactive customer engagement.
Summing Up,
The companies that recognise Predictive AI early and invest in building those capabilities now, will not just be more competitive. They will be more relevant. In an industry that has long struggled to convince Indian consumers that health insurance is something they want rather than something they grudgingly need, that relevance may be the most valuable thing of all.
Sources:
Author: Dr. Kavindra Kumar Singh, Chief Technology Officer, SMC Insurance Brokers Pvt Ltd
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of IIA, and IIA does not assume any responsibility or liability for the same.
